Neogen (NEOG) Income from Continuing Operations (2010 - 2026)

Neogen's (NEOG) quarterly Income from Continuing Operations came in at 17000000.0 in Q1 2026, down 55.96% year-on-year from 38604166.67 in Q1 2025, and down 6.76% quarter-over-quarter from 15924000.0 in Q4 2025.

Neogen (NEOG) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Neogen's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 17000000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 55.96% year-over-year to 17000000.0 in Q1 2026; TTM through Feb 2026 was 648025000.0, a 33.56% decrease from a year earlier, with the FY2025 full-year figure at 1131239000.0, down 11907.63% from the prior year.
  • Income from Continuing Operations declined to 17000000.0 in Q1 2026 per NEOG's latest filing, from 15924000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 36338000.0 in Q3 2025 and bottomed at 651439000.0 in Q2 2025.
  • The 5-year median for Income from Continuing Operations is 3487000.0 (2023), against an average of 67037529.41.
  • Across the five-year window, Income from Continuing Operations tumbled 12985.23% in 2024 and soared 388.19% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 41841000.0 in 2022, then surged by 91.67% to 3487000.0 in 2023, then tumbled by 12985.23% to 456282000.0 in 2024, then soared by 96.51% to 15924000.0 in 2025, then fell by 6.76% to 17000000.0 in 2026.
  • Per Business Quant, the three latest NEOG Income from Continuing Operations figures stand at 17000000.0 (Q1 2026), 15924000.0 (Q4 2025), and 36338000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Neogen 2.09 Bn 1.93 Bn 99.00 Mn -17.00 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -17.00 Mn
Nov 30, 2025 -15.92 Mn
Aug 31, 2025 36.34 Mn
May 31, 2025 -651.44 Mn
Feb 28, 2025 -10.90 Mn
Nov 30, 2024 -456.28 Mn
Aug 31, 2024 -12.61 Mn
May 31, 2024 -5.42 Mn
Feb 29, 2024 -2.02 Mn
Nov 30, 2023 -3.49 Mn
Aug 31, 2023 1.50 Mn
May 31, 2023 6.38 Mn
Feb 28, 2023 8.19 Mn
Nov 30, 2022 -41.84 Mn
Aug 31, 2022 5.21 Mn
May 31, 2022 14.22 Mn
Feb 28, 2022 5.44 Mn
Nov 30, 2021 10.83 Mn
Aug 31, 2021 17.08 Mn
May 31, 2021 14.34 Mn